# Dexmedetomidine Supplemented Analgesia and Delirium After Hip Fracture Surgery

> **NCT04955249** · PHASE4 · TERMINATED · sponsor: **Peking University First Hospital** · enrollment: 67 (actual)

## Conditions studied

- Elderly
- Hip Fracture Surgery
- Patient-controlled Analgesia
- Dexmedetomidine
- Postoperative Delirium

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04955249
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-18
- **Primary completion:** 2023-04-11
- **Final completion:** 2023-05-11
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** Stopped prematurely because of too few cases.
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04955249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04955249, "Dexmedetomidine Supplemented Analgesia and Delirium After Hip Fracture Surgery". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT04955249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*